Patents by Inventor Tomohisa Kuzuyama
Tomohisa Kuzuyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10280406Abstract: The object of the present invention is to efficiently produce useful terpenoid compounds, and specifically, to provide a method for preparing squalene, which is an important intermediate of terpenoid. The object can be solved by a hydroxymethylglutaryl CoA reductase (HMGR) comprising: (a) an amino acid other than alanine (A) at the 10th position in an S?2 amino acid sequence of HMGR, (b) an amino acid other than proline (P) at the 1st position from the carboxyl terminal in the DKK region of the HMG-CoA binding site of HMGR, (c) an amino acid other than alanine (A) at the 1st position in an L?2 amino acid sequence of HMGR, and (d) an amino acid other than glutamic acid (E) at the 6th position in an L?2 amino acid sequence of HMGR of the present invention.Type: GrantFiled: April 9, 2015Date of Patent: May 7, 2019Assignee: ADEKA CORPORATIONInventors: Toshihiko Takehana, Seiji Koike, Tomohisa Kuzuyama
-
Publication number: 20170088824Abstract: The object of the present invention is to efficiently produce useful terpenoid compounds, and specifically, to provide a method for preparing squalene, which is an important intermediate of terpenoid. The object can be solved by a hydroxymethylglutaryl CoA reductase (HMGR) comprising:(a) an amino acid other than alanine (A) at the 10th position in an S?2 amino acid sequence of HMGR, (b) an amino acid other than proline (P) at the 1st position from the carboxyl terminal in the DKK region of the HMG-CoA binding site of HMGR, (c) an amino acid other than alanine (A) at the 1st position in an L?2 amino acid sequence of HMGR, and (d) an amino acid other than glutamic acid (E) at the 6th position in an L?2 amino acid sequence of HMGR of the present invention.Type: ApplicationFiled: April 9, 2015Publication date: March 30, 2017Inventors: Toshihiko TAKEHANA, Seiji KOIKE, Tomohisa KUZUYAMA
-
Patent number: 9005953Abstract: This invention relates to a recombinant microorganism having improved butanol production capacity and butanol production with the use of such recombinant microorganism with good efficiency. In this invention, the acetoacetyl-CoA synthase gene encoding an enzyme capable of synthesizing acetoacetyl-CoA from malonyl-CoA and acetyl-CoA and a group of genes involved in butanol biosynthesis that enables synthesis of butanol from acetoacetyl-CoA are introduced into a host microorganism.Type: GrantFiled: May 6, 2010Date of Patent: April 14, 2015Assignee: Toyota Jidosha Kabushiki KaishaInventors: Masayoshi Muramatsu, Shusei Obata, Satoshi Yoneda, Masahiro Sugimura, Tomohisa Kuzuyama
-
Patent number: 8124390Abstract: In accordance with the present invention, a novel aromatic prenyltransferase, Orf2 from Streptomyces sp. strain CL190, involved in naphterpin biosynthesis has been identified and the structure thereof elucidated. This prenyltransferase catalyzes the formation of a C—C bond between a prenyl group and a compound containing an aromatic nucleus, and also displays C—O bond formation activity. Numerous crystallographic structures of the prenyltransferase have been solved and refined, e.g., (1) prenyltransferase complexed with a buffer molecule (TAPS), (2) prenyltransferase as a binary complex with geranyl diphosphate (GPP) and Mg2+, and prenyltransferase as ternary complexes with a non-hydrolyzable substrate analogue, geranyl S-thiolodiphosphate (GSPP) and either (3) 1,6-dihydroxynaphthalene (1,6-DHN), or (4) flaviolin (i.e., 2,5,7-trihydroxy-1,4-naphthoquinone, which is the oxidized product of 1,3,6,8-tetrahydroxynaphthalene (THN)). These structures have been solved and refined to 1.5 ?, 2.25 ?, 1.95 ? and 2.Type: GrantFiled: June 8, 2009Date of Patent: February 28, 2012Assignees: The Salk Institute for Biological Studies, Toudai TLO, Ltd.Inventors: Tomohisa Kuzuyama, Joseph P. Noel, Stephane P. Richard
-
Publication number: 20100285549Abstract: This invention relates to a recombinant microorganism having improved butanol production capacity and butanol production with the use of such recombinant microorganism with good efficiency. In this invention, the acetoacetyl-CoA synthase gene encoding an enzyme capable of synthesizing acetoacetyl-CoA from malonyl-CoA and acetyl-CoA and a group of genes involved in butanol biosynthesis that enables synthesis of butanol from acetoacetyl-CoA are introduced into a host microorganism.Type: ApplicationFiled: May 6, 2010Publication date: November 11, 2010Applicant: TOYOTA JIDOSHA KABUSHIKI KAISHAInventors: MASAYOSHI MURAMATSU, SHUSEI OBATA, SATOSHI YONEDA, MASAHIRO SUGIMURA, TOMOHISA KUZUYAMA
-
Publication number: 20100285502Abstract: In accordance with the present invention, a novel aromatic prenyltransferase, Orf2 from Streptomyces sp. strain CL190, involved in naphterpin biosynthesis has been identified and the structure thereof elucidated. This prenyltransferase catalyzes the formation of a C—C bond between a prenyl group and a compound containing an aromatic nucleus, and also displays C—O bond formation activity. Numerous crystallographic structures of the prenyltransferase have been solved and refined, e.g., (1) prenyltransferase complexed with a buffer molecule (TAPS), (2) prenyltransferase as a binary complex with geranyl diphosphate (GPP) and Mg2+, and prenyltransferase as ternary complexes with a non-hydrolyzable substrate analogue, geranyl S-thiolodiphosphate (GSPP) and either (3) 1,6-dihydroxynaphthalene (1,6-DHN), or (4) flaviolin (i.e., 2,5,7-trihydroxy-1,4-naphthoquinone, which is the oxidized product of 1,3,6,8-tetrahydroxynaphthalene (THN)). These structures have been solved and refined to 1.5 ?, 2.25 ?, 1.95 ? and 2.Type: ApplicationFiled: June 8, 2009Publication date: November 11, 2010Inventors: Tomohisa Kuzuyama, Joseph P. Noel, Stephane P. Richard
-
Patent number: 7544498Abstract: In accordance with the present invention, a novel aromatic prenyltransferase, Orf2 from Streptomyces sp. strain CL190, involved in naphterpin biosynthesis has been identified and the structure thereof elucidated. This prenyltransferase catalyzes the formation of a C—C bond between a prenyl group and a compound containing an aromatic nucleus, and also displays C—O bond formation activity. Numerous crystallographic structures of the prenyltransferase have been solved and refined, e.g., (1) prenyltransferase complexed with a buffer molecule (TAPS), (2) prenyltransferase as a binary complex with geranyl diphosphate (GPP) and Mg2+, and prenyltransferase as ternary complexes with a non-hydrolyzable substrate analogue, geranyl S-thiolodiphosphate (GSPP) and either (3) 1,6-dihydroxynaphthalene (1,6-DHN), or (4) flaviolin (i.e., 2,5,7-trihydroxy-1,4-naphthoquinone, which is the oxidized product of 1,3,6,8-tetrahydroxynaphthalene (THN)). These structures have been solved and refined to 1.5 ?, 2.25 ?, 1.95 ? and 2.Type: GrantFiled: April 18, 2008Date of Patent: June 9, 2009Assignees: The Salk Institute for Biological Studies, Toudai TLO, Ltd.Inventors: Tomohisa Kuzuyama, Joseph P. Noel, Stephane P. Richard
-
Patent number: 7531333Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: GrantFiled: August 13, 2007Date of Patent: May 12, 2009Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi
-
Publication number: 20080274478Abstract: In accordance with the present invention, a novel aromatic prenyltransferase, Orf2 from Streptomyces sp. strain CL190, involved in naphterpin biosynthesis has been identified and the structure thereof elucidated. This prenyltransferase catalyzes the formation of a C—C bond between a prenyl group and a compound containing an aromatic nucleus, and also displays C—O bond formation activity. Numerous crystallographic structures of the prenyltransferase have been solved and refined, e.g., (1) prenyltransferase complexed with a buffer molecule (TAPS), (2) prenyltransferase as a binary complex with geranyl diphosphate (GPP) and Mg2+, and prenyltransferase as ternary complexes with a non-hydrolyzable substrate analogue, geranyl S-thiolodiphosphate (GSPP) and either (3) 1,6-dihydroxynaphthalene (1,6-DHN), or (4) flaviolin (i.e., 2,5,7-trihydroxy-1,4-naphthoquinone, which is the oxidized product of 1,3,6,8-tetrahydroxynaphthalene (THN)). These structures have been solved and refined to 1.5 ?, 2.25 ?, 1.95 ? and 2.Type: ApplicationFiled: April 18, 2008Publication date: November 6, 2008Inventors: Tomohisa Kuzuyama, Joseph P. Noel, Stephane P. Richard
-
Publication number: 20080227141Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: ApplicationFiled: March 11, 2008Publication date: September 18, 2008Applicant: KYOWA HAKKO KOGYO CO., LTD.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi
-
Publication number: 20080131926Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: ApplicationFiled: August 13, 2007Publication date: June 5, 2008Applicant: KYOWA HAKKO KOGYO CO., LTD.Inventors: Koichiro MIYAKE, Shinichi HASHIMOTO, Hiroaki MOTOYAMA, Akio OZAKI, Haruo SETO, Tomohisa KUZUYAMA, Shunji TAKAHASHI
-
Patent number: 7364885Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: GrantFiled: April 2, 2007Date of Patent: April 29, 2008Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi
-
Patent number: 7361483Abstract: In accordance with the present invention, a novel aromatic prenyltransferase, Orf2 from Streptomyces sp. strain CL190, involved in naphterpin biosynthesis has been identified and the structure thereof elucidated. This prenyltransferase catalyzes the formation of a C—C bond between a prenyl group and a compound containing an aromatic nucleus, and also displays C—O bond formation activity. Numerous crystallographic structures of the prenyltransferase have been solved and refined, e.g., (1) prenyltransferase complexed with a buffer molecule (TAPS), (2) prenyltransferase as a binary complex with geranyl diphosphate (GPP) and Mg2+, and prenyltransferase as ternary complexes with a non-hydrolyzable substrate analogue, geranyl S-thiolodiphosphate (GSPP) and either (3) 1,6-dihydroxynaphthalene (1,6-DHN), or (4) flaviolin (i.e., 2,5,7-trihydroxy-1,4-naphthoquinone, which is the oxidized product of 1,3,6,8-tetrahydroxynaphthalene (THN)). These structures have been solved and refined to 1.5 ?, 2.25 ?, 1.95 ? and 2.Type: GrantFiled: January 27, 2006Date of Patent: April 22, 2008Assignees: The Salk Institute for Biological Studies, Toudai TLO, Ltd.Inventors: Tomohisa Kuzuyama, Joseph P. Noel, Stephane P. Richard
-
Publication number: 20070269857Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: ApplicationFiled: April 2, 2007Publication date: November 22, 2007Applicant: KYOWA HAKKO KOGYO CO., LTD.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi
-
Patent number: 7208298Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: GrantFiled: May 24, 2006Date of Patent: April 24, 2007Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi
-
Publication number: 20070004000Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: ApplicationFiled: May 24, 2006Publication date: January 4, 2007Applicant: KYOWA HAKKO KOGYO CO., LTD.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi
-
Patent number: 7132268Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: GrantFiled: September 13, 2004Date of Patent: November 7, 2006Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi
-
Publication number: 20060183211Abstract: In accordance with the present invention, a novel aromatic prenyltransferase, Orf2 from Streptomyces sp. strain CL190, involved in naphterpin biosynthesis has been identified and the structure thereof elucidated. This prenyltransferase catalyzes the formation of a C—C bond between a prenyl group and a compound containing an aromatic nucleus, and also displays C—O bond formation activity. Numerous crystallographic structures of the prenyltransferase have been solved and refined, e.g., (1) prenyltransferase complexed with a buffer molecule (TAPS), (2) prenyltransferase as a binary complex with geranyl diphosphate (GPP) and Mg2+, and prenyltransferase as ternary complexes with a non-hydrolyzable substrate analogue, geranyl S-thiolodiphosphate (GSPP) and either (3) 1,6-dihydroxynaphthalene (1,6-DHN), or (4) flaviolin (i.e., 2,5,7-trihydroxy-1,4-naphthoquinone, which is the oxidized product of 1,3,6,8-tetrahydroxynaphthalene (THN)). These structures have been solved and refined to 1.5 ?, 2.25 ?, 1.95 ? and 2.Type: ApplicationFiled: January 27, 2006Publication date: August 17, 2006Inventors: Tomohisa Kuzuyama, Joseph Noel, Stephane Richard
-
Publication number: 20050032169Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles; the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: ApplicationFiled: September 13, 2004Publication date: February 10, 2005Applicant: KYOWA HAKKO KOGYO CO., LTD.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi
-
Patent number: 6806076Abstract: The present invention provides a process for producing isoprenoid compounds or proteins encoded by DNA using DNA that contains one or more of the DNA encoding proteins having activity to improve efficiency in the biosynthesis of isoprenoid compounds effective in pharmaceuticals for cardiac diseases, osteoporosis, homeostasis, prevention of cancer, and immunopotentiation, health food and anti-fouling paint products against barnacles the DNA; the protein; and a method for screening a substance with antibiotic and weeding activities comprising screening a substance inhibiting enzymatic reaction on the non-mevalonate pathway.Type: GrantFiled: October 12, 2000Date of Patent: October 19, 2004Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Koichiro Miyake, Shinichi Hashimoto, Hiroaki Motoyama, Akio Ozaki, Haruo Seto, Tomohisa Kuzuyama, Shunji Takahashi